Canada has a national asset in life sciences. Now what?

Published on April 27, 2026

The Hill Times

Read more here (Subscription required)

Continue reading on website
Other news

Canadian life sciences is at a “generational moment,” but experts disagree on its future

April 27, 2026
At MaRS Impact Health in Toronto Thursday morning, industry leaders gathered on stage to share contrasting perspectives on what Canadian governments should—and should not— do to support the growth in Canada’s life sciences sector.“If I’m ever a patient on the table, don’t give me the best Canadian [option] … I want the best of the world.”Brian BloomDespite the county’s many successful startups and

BIOTECanada responds to Health Canada’s Gazette on a draft Order Providing for Reliance on International Regulatory Authorities

April 28, 2026
BIOTECanada welcomed Health Canada’s proposal to leverage foreign regulatory authority decisions as part of the Red Tape Review initiative and recognizes this as a meaningful step toward improving timely access to medicines for Canadians.  To fully realize the benefits of the Order and the reliance pathway, BIOTECanada recommended broadening the scope of the medicines considered under the Reliance